Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
SAR | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 879 | 901 | 855 | 764 | 708 | 809 | 845 | 918 | 1,082 | 1,294 | | 1,294 |
% Growth | NA | 2.5% | -5.1% | -10.7% | -7.3% | 14.2% | 4.5% | 8.6% | 17.8% | 19.6% | | |
| | | | | | | | | | | | |
Cost of Revenue | (663) | (697) | (665) | (603) | (547) | (588) | (601) | (631) | (715) | (845) | | (845) |
Gross Profit | 216 | 204 | 190 | 161 | 162 | 221 | 244 | 287 | 367 | 449 | | 449 |
% Revenue | 24.6% | 22.7% | 22.2% | 21.1% | 22.8% | 27.3% | 28.9% | 31.3% | 33.9% | 34.7% | | 34.7% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (2) | (1) | (0) | (0) | (6) | (42) | (2) | (4) | (9) | (11) | | (11) |
General and Admin | (85) | (124) | (100) | (81) | (67) | (65) | (86) | (94) | (116) | (189) | | (189) |
Other Inc / (Exp) | 14 | (8) | 13 | 5 | 10 | 9 | 8 | 8 | 4 | 49 | | 49 |
Total Operating Exp | (73) | (133) | (87) | (76) | (63) | (98) | (80) | (90) | (120) | (152) | | (152) |
| | | | | | | | | | | | |
Operating Income | 143 | 71 | 103 | 85 | 98 | 123 | 164 | 197 | 247 | 297 | | 297 |
% Revenue | 16.3% | 7.9% | 12.0% | 11.1% | 13.9% | 15.2% | 19.4% | 21.5% | 22.8% | 22.9% | | 22.9% |
| | | | | | | | | | | | |
Interest Expense | (1) | (4) | (2) | (1) | 5 | 0 | 0 | 1 | 18 | (3) | | (3) |
Pre-tax Income | 142 | 67 | 100 | 84 | 103 | 123 | 164 | 199 | 265 | 294 | | 294 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (11) | (17) | (15) | (21) | (23) | (26) | (28) | (28) | (24) | 5 | | 5 |
Net Income to Company | 131 | 50 | 85 | 62 | 80 | 97 | 136 | 170 | 241 | 298 | | 298 |
% Margin | 14.9% | 5.6% | 10.0% | 8.1% | 11.3% | 12.0% | 16.1% | 18.5% | 22.3% | 23.0% | | 23.0% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 131 | 50 | 85 | 62 | 80 | 97 | 136 | 170 | 241 | 298 | | 298 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 131 | 50 | 85 | 62 | 80 | 97 | 136 | 170 | 241 | 298 | | 298 |
% Margin | 14.9% | 5.6% | 10.0% | 8.1% | 11.3% | 12.0% | 16.1% | 18.5% | 22.3% | 23.0% | | 23.0% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 2.91 | 1.12 | 1.90 | 1.39 | 1.79 | 2.17 | 3.04 | 3.79 | 5.37 | 6.66 | | 6.66 |
Diluted EPS (Continuing Ops) | 2.91 | 1.12 | 1.90 | 1.39 | 1.79 | 2.17 | 3.04 | 3.79 | 5.37 | 6.66 | | 6.66 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.77 | | 44.77 |
WA Diluted Shares Out. | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.85 | 44.77 | | 44.77 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 142 | 67 | 100 | 84 | 103 | 123 | 164 | 199 | 265 | 294 | | 294 |
Addback: Net Interest Expense | 1 | 4 | 2 | 1 | (5) | (0) | 0 | (1) | (18) | 3 | | 3 |
Addback: Other Non Operating Expenses, Total | (12) | 0 | 0 | (7) | (10) | (9) | 0 | 0 | 0 | 0 | | 0 |
Addback: Depreciation & Amortization | 59 | 66 | 68 | 73 | 69 | 56 | 50 | 42 | 44 | 61 | | 61 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | (2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (42) | | (42) |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 187 | 137 | 172 | 153 | 157 | 170 | 215 | 239 | 291 | 315 | | 315 |
% Margin | 21.3% | 15.2% | 20.1% | 20.0% | 22.2% | 21.1% | 25.4% | 26.1% | 26.9% | 24.4% | | 24.4% |
| | | | | | | | | | | | |
Adjusted EBIT | 129 | 71 | 104 | 80 | 88 | 114 | 164 | 197 | 247 | 255 | | 255 |
% Margin | 14.6% | 7.9% | 12.1% | 10.5% | 12.5% | 14.1% | 19.4% | 21.5% | 22.8% | 19.7% | | 19.7% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 131 | 50 | 85 | 62 | 80 | 97 | 136 | 170 | 241 | 298 | | 298 |
Addback: Unusual Items | (2) | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | (42) | | (42) |
Less: Tax Benefit of Unusual Items (26%) | 1 | 0 | (0) | (1) | 0 | 0 | 0 | 0 | 0 | 11 | | 11 |
Adjusted Net Income | 129 | 50 | 86 | 64 | 80 | 97 | 136 | 170 | 241 | 267 | | 267 |
% Margin | 14.7% | 5.6% | 10.1% | 8.4% | 11.3% | 12.0% | 16.1% | 18.5% | 22.3% | 20.6% | | 20.6% |